Skip to main content
Mark Buchfuhrer, MD, Pulmonology, Downey, CA

MarkJosephBuchfuhrerMD

Pulmonology • Downey, CA

Pleural Disease, Sleep Medicine

Consulting Assistant Professor, Stanford University School of Medicine

Join to view full profile

Dr. Buchfuhrer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Buchfuhrer's full profile

Already have an account?

  • Office

    11480 Brookshire Avenue
    # 108
    Downey, CA 90241
    Phone+1 562-904-1101
    Fax+1 562-904-1105

Education & Training

  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterInternship, Transitional Year, 1980 - 1981
  • University of Ottawa Faculty of Medicine
    University of Ottawa Faculty of MedicineClass of 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1979 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AASM’s New RLS Guidelines Recommend Peroneal Nerve Stimulation Therapy
    AASM’s New RLS Guidelines Recommend Peroneal Nerve Stimulation TherapyOctober 8th, 2024
  • Noctrix Health Secures $40 Million Series C Financing to Commercialize Novel Device Treatment for Restless Legs Syndrome (Rls)
    Noctrix Health Secures $40 Million Series C Financing to Commercialize Novel Device Treatment for Restless Legs Syndrome (Rls)August 19th, 2024
  • Noctrix Health Announces Enrollment of First Patient in the RESTFUL Study and Publication of Positive Pilot Study Results
    Noctrix Health Announces Enrollment of First Patient in the RESTFUL Study and Publication of Positive Pilot Study ResultsMay 25th, 2021
  • Join now to see all

Professional Memberships

Dr. Mark Buchfuhrer, Dr. Mark Buchfuhrer, MD, Dr. M Buchfuhrer, Dr. Mark Joseph Buchfuhrer